Why the study?
Routine preoperative complementary tests are frequently ordered despite questionable clinical contribution, prompting investigation into whether they are truly indicated or unjustified in pediatric elective minor and medium surgeries.
Are systematic preoperative complementary tests indicated and cost-effective in children undergoing elective minor and medium surgeries?
Are systematic preoperative complementary tests indicated and cost-effective in children undergoing elective minor and medium surgeries?
Routine systematic preoperative blood testing in pediatric elective surgery is largely non-indicated and results in unnecessary healthcare costs, supporting a shift toward selective, guideline-based testing.
Routine preoperative tests lack indication in most low-risk pediatric cases; supports selective ordering but leaves open outcome and cost effects.
Introduction: Prescription of routine complementary tests preoperatively has become a tradition for all practitioners. These tests are ordered frequently but their contribution doesn’t seem that significant. The aim of our study is to find out whether these systematic preoperative tests, prescribed for children undergoing elective minor and medium surgeries, were truly indicated or unjustified. Patients and Methods: We conducted a prospective, observational study including 230 children admitted for scheduled surgery with minor to medium bleeding risk. Several parameters were collected: the surgery and anesthesia characteristics, complementary preoperative tests, the tests prescriber, their usefulness and the cost of the prescription. Results: The mean age was 3 years old. The majority (95%) belonged to ASA I class. Twenty-eight percent of these children couldn’t walk yet. Eighty-two percent of the undergone surgeries had a minor bleeding risk. In 74% of cases, the chosen technique was a general anesthesia combined to local anesthesia. For the 230 patients studied, 857 complementary tests were requested. A systematic blood assessment was performed for all the patients. Only 35,86% of the realized tests were actually indicated. Excluding blood group, analysis of other tests showed that only 28,71% of them were abnormal. The total cost of the complementary tests was 8919.1 dinars of which 64,14% were spent on non-indicated tests. Conclusion: The systematic routine prescribing of blood tests must be forsaken to switch to a selective and rational prescription. Recommendations and guidelines may afford a precious help to organize the blood tests prescription procedure.
No takes yet. Share an insight, caveat, or question.
Gafsi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: